NCT00117338View on ClinicalTrials.gov

A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)

PHASE3CompletedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Asthma
Interventions
DRUG

montelukast sodium

Montelukast IV 5.25 mg lyophilized (reconstituted in 20 mL of 3.3% dextrose/0.3% sodium chloride) for a study approximately 120 minutes in duration

DRUG

Comparator: placebo (unspecified)

Pbo for a study approximately 120 minutes in duration

All Listed Sponsors
lead

Organon and Co

INDUSTRY